Lucy C. Freytag
Affiliations: | Microbiology & Immunology | Tulane University, New Orleans, LA, United States |
Area:
Immunology, Microbiology BiologyGoogle:
"Lucy Freytag"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Frederick DR, Goggins JA, Sabbagh LM, et al. (2017) Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4 T cells following parenteral immunization. Mucosal Immunology. 11: 549-561 |
| Clements JD, Freytag LC. (2016) Parenteral Vaccination Can Be An Effective Means of Inducing Protective Mucosal Responses. Clinical and Vaccine Immunology : Cvi |
| Li T, Steede NK, Nguyen HN, et al. (2014) Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein. Journal of Virology. 88: 9605-15 |
| Steede NK, Rust BJ, Hossain MM, et al. (2013) Shaping T cell - B cell collaboration in the response to human immunodeficiency virus type 1 envelope glycoprotein gp120 by peptide priming. Plos One. 8: e65748 |
| Tomchuck SL, Norton EB, Garry RF, et al. (2012) Mesenchymal stem cells as a novel vaccine platform. Frontiers in Cellular and Infection Microbiology. 2: 140 |
| Norton EB, Lawson LB, Mahdi Z, et al. (2012) The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens. Infection and Immunity. 80: 2426-35 |
| Lawson LB, Clements JD, Freytag LC. (2012) Mucosal immune responses induced by transcutaneous vaccines. Current Topics in Microbiology and Immunology. 354: 19-37 |
| Norton EB, Lawson LB, Freytag LC, et al. (2011) Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clinical and Vaccine Immunology : Cvi. 18: 546-51 |
| Lawson LB, Freytag LC, Clements JD. (2007) Use of nanocarriers for transdermal vaccine delivery. Clinical Pharmacology and Therapeutics. 82: 641-3 |
| Uddowla S, Freytag LC, Clements JD. (2007) Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens. Vaccine. 25: 7984-93 |